TCV Trust & Wealth Management’s Elevance Health ELV Stock Holding History

TCV Trust & Wealth Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-386	Closed	-$200K	–	201
2024 Q1	$200K	Sell	386 -43	-10%	-$21.4K	0.02%	197
2023 Q4	$202K	Sell	429 -185	-30%	-$85.5K	0.02%	188
2023 Q3	$267K	Buy	+614	New	+$278K	0.03%	166
2023 Q1	–	Sell	-411	Closed	-$211K	–	191
2022 Q4	$211K	Buy	+411	New	+$209K	0.02%	182
2022 Q3	–	Sell	-441	Closed	-$212K	–	186
2022 Q2	$212K	Hold	441	–	–	0.03%	191
2022 Q1	$216K	Sell	441 -400	-48%	-$183K	0.02%	196
2021 Q4	$390K	Buy	841 +51	+6%	+$21.5K	0.04%	160
2021 Q3	$295K	Buy	+790	New	+$300K	0.03%	166
2019 Q3	–	Sell	-937	Closed	-$265K	–	198
2019 Q2	$265K	Buy	937 +64	+7%	+$17.5K	0.03%	176
2019 Q1	$250K	Buy	+873	New	+$252K	0.03%	185

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

TCV Trust & Wealth Management's ELV Position: Q2 2024 in Review

TCV Trust & Wealth Management sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 386 shares — an estimated $200K sold.

TCV Trust & Wealth Management first reported a position in ELV in Q1 2019 and held it in 10 quarters. The position peaked at $390K in Q4 2021. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

TCV Trust & Wealth Management reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
TCV Trust & Wealth Management sold 386 Elevance Health shares in Q2 2024, an estimated $200K.
TCV Trust & Wealth Management first reported a position in Elevance Health in Q1 2019 and held it in 10 quarters.
TCV Trust & Wealth Management's Elevance Health position peaked at $390K in Q4 2021.
1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on TCV Trust & Wealth Management's 13F filing for Q2 2024, filed 26 Jul 2024.